Different toxicity rating patients and physicians in randomized phase III PCI vs obs stage III NSCLC

Authors
Category Primary study
JournalRadiotherapy and Oncology
Year 2018
This article has no abstract
Epistemonikos ID: 6f8ee689542e8244bb7a9200d8bec98f6ebca3ea
First added on: Feb 09, 2025